RBC Capital Starts Moderna (MRNA) at Outperform, 'We Are Cancer Vaccine Believers'
Tweet Send to a Friend
RBC Capital analyst Luca Issi initiates coverage on Moderna (NASDAQ: MRNA) with a Outperform rating and a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
